Neurotoxicity of Inhalation Anesthetics in the Neonatal Rat Brain: Effects on Behavior and Neurodegeneration in the Piriform Cortex

Anesthesiology Research and Practice
Rachel A O'FarrellHelen C Gallagher

Abstract

There is concern that clinical use of anesthetic drugs may cause neurotoxicity in the developing brain and subsequent abnormal neurobehavior. We therefore evaluated neurotoxic effects of inhalation anesthetics in the neonatal rat brain, using in vivo histological and neurobehavioral outcomes. Wistar rats (n=79, postnatal day 15) were subjected to a clinically relevant single exposure of urethane, isoflurane, sevoflurane, or placebo, without surgery. At 48 h and 96 h, behavioral parameters were recorded and the animals were sacrificed. In cryosectioned brains, total cells and dying cells in layer II of the piriform cortex were counted using unbiased stereology. At 48 h, cell numbers in layer II of the piriform cortex of all drug-treated animals were reduced versus controls (p=0.01). The effect persisted at 96 h in isoflurane- and urethane-exposed animals. Piriform cortical layer II neurons undergoing degeneration, detected histologically by pyknotic nuclei and eosinophilic cytoplasm, were increased in the animals treated with isoflurane (1.9 ± 0.7 at 96 h) and urethane (2.4 ± 0.8 at 96 h) versus sevoflurane (0.8 ± 0.3 at 96 h) and controls (0.9 ± 0.2 at 96 h). Sevoflurane- and isoflurane-treated animals exhibited increased activ...Continue Reading

References

Mar 1, 1979·Early Human Development·J Dobbing, J Sands
Dec 1, 1995·Anesthesia and Analgesia·I SmithP F White
Feb 18, 1998·Neuroscience·K ThompsonC Wasterlain
Mar 10, 2000·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·G O'LearyC M Regan
Jun 22, 2001·Chemical Senses·C Linster, M E Hasselmo
Oct 25, 2001·Brain Research. Developmental Brain Research·K W Thompson, C G Wasterlain
Nov 6, 2002·Proceedings of the National Academy of Sciences of the United States of America·Petra BittigauChrysanthy Ikonomidou
Sep 23, 2003·Cell Death and Differentiation·C YoungJ W Olney
Mar 23, 2004·Current Molecular Medicine·Chainllie YoungJohn W Olney
Jul 28, 2004·Anesthesiology·Kanwaljeet J S Anand, Sulpicio G Soriano
Feb 3, 2005·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Denise RohanDenis C Moriarty
Sep 27, 2005·Journal of Neurosurgical Anesthesiology·Sulpicio G Soriano, Andreas W Loepke
Mar 15, 2006·Current Opinion in Anaesthesiology·Sulpicio G Soriano, Kanwaljeet Js Anand
Apr 11, 2006·Neuroreport·Anton PekcecHeidrun Potschka
Apr 12, 2007·Toxicological Sciences : an Official Journal of the Society of Toxicology·William SlikkerCheng Wang
Jan 30, 2008·Anesthesia and Analgesia·Ge LiangHuafeng Wei
May 24, 2008·Anesthesia and Analgesia·Davide CattanoJohn W Olney
Nov 27, 2008·Anesthesiology·Andrew J DavidsonPaul S Myles
Dec 22, 2010·British Journal of Anaesthesia·L Sun
Mar 11, 2011·The New England Journal of Medicine·Bob RappaportJanet Woodcock
May 28, 2011·British Journal of Anaesthesia·A E Hudson, H C Hemmings
Oct 25, 2011·Anesthesia and Analgesia·James G Ramsay, Bob A Rappaport
Oct 19, 2012·Journal of Neurosurgical Anesthesiology·Lena S SunFrancis X McGowan
Jul 13, 2013·Frontiers in Neurology·Kathy L Murphy, Mark G Baxter
Oct 2, 2015·Toxicological Sciences : an Official Journal of the Society of Toxicology·Lin QiuNiccolò Terrando
Aug 19, 2017·Current Pharmaceutical Design·Maria Fernanda Quiroz-PadillaRosa Margarita Gomez

❮ Previous
Next ❯

Software Mentioned

Leica Quantimet 500
GraphPad Prism
SmartTots

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.